查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855904

2025年全球免疫基因體學市場報告

Immunogenomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，免疫基因組學市場發展迅速，預計從2024年的52.4億美元成長到2025年的60.9億美元，複合年成長率達16.3%。過去研究期間的成長與自體免疫疾病盛行率上升、個人化醫療需求增加、人們對免疫基因組學檢測的認知不斷提高、政府對醫療保健研究的資助以及生物技術和製藥行業的擴張有關。

預計未來幾年免疫基因組學市場將快速成長，到2029年市場規模將達到110億美元，複合年成長率（CAGR）為15.9%。預測期內的成長主要得益於免疫基因組學療法的廣泛應用、精準醫療的不斷推進、研發投入的增加、醫療基礎設施的完善以及對診斷解決方案需求的不斷成長。預測期內的關鍵趨勢包括定序和基因型鑒定技術的進步、免疫基因組學檢測方法的創新、生物資訊學和數據分析的進展、標靶治療的開發以及人工智慧在免疫基因組學中的應用。

免疫基因組學是基因組學的一個分支，它研究個體的基因組成如何影響其免疫系統的功能。它專注於識別影響免疫反應、感染疾病和自體免疫疾病易感性以及免疫療法和疫苗有效性的基因變異。

免疫基因組學的主要產品類型包括儀器、耗材、軟體和服務。儀器是用於分析遺傳物質和研究免疫系統的實驗室設備，包括定序儀、微陣列掃描儀和細胞分選儀。所採用的技術包括次世代定序儀、微陣列和聚合酵素鏈鎖反應）。應用領域涵蓋腫瘤學、感染疾病、自體免疫疾病和移植等領域，公司服務於醫院和診所、研究機構、製藥和生物技術公司以及其他終端用戶。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，該系列報告提供免疫基因組學市場統計數據，例如全球免疫基因組學市場規模、區域佔有率、市場佔有率及競爭對手、詳細的市場細分、市場趨勢和機遇，以及在免疫基因組學行業取得成功所需的數據。本免疫基因組學市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供觀點的全面資訊。

預計感染疾病的日益普及將推動免疫基因組學市場在不久的將來成長。感染疾病是由細菌、病毒、真菌和寄生蟲等有害微生物引起的疾病，可透過直接或間接途徑在人與人之間傳播。這些疾病發病率的上升主要是由於全球旅行的增加，這促進了病原體跨境的快速傳播。免疫基因組學透過精確分析宿主的免疫反應和遺傳易感性，有助於感染疾病的管理。這種方法透過識別患者特異性的免疫因素，減少了治療中的試驗，從而改善了診斷、疫苗研發和個人化治療策略。例如，英國衛生安全局在2024年2月報告稱，英格蘭的結核病病例數將在2023年比2022年的4380例增加10.7%，達到4850例。因此，感染疾病的增加正在推動免疫基因組學市場的成長。

免疫基因組學市場的主要企業正致力於開發尖端技術，例如單細胞轉錄組解決方案，以高解析度分析免疫細胞多樣性，並加深對複雜免疫反應的理解。單細胞轉錄組解決方案能夠分析單一細胞內的全部RNA轉錄本，從而深入了解複雜組織內的基因表現模式和細胞異質性。例如，2022年10月，加州太平洋生物科學公司（Pacific Biosciences of California Inc.）與10x Genomics公司合作，並與麻省理工學院和哈佛大學博德研究所（Broad Institute of MIT and Harvard）共同推出了多重陣列定序（MAS-Seq）套件。這種高通量、具成本效益的定序解決方案能夠對單細胞RNA轉錄物進行全長分析，從而以極高的精度發現新的RNA異構體和突變。該技術透過連接cDNA分子，將定序通量提高了16倍，並可與10x Genomics的單細胞技術和PacBio定序儀無縫整合。該解決方案使研究人員能夠探索異構體水平的細胞異質性，從而推進疾病研究和生物標記發現。

2025年1月，美國生物技術公司Adaptive Biotechnologies Corp.與NeoGenomics Laboratories Inc.達成合作，以提升其先進的免疫基因組學檢測服務。此次合作旨在擴大血液腫瘤患者獲得個人化微量殘存疾病（MRD）監測的機會，並透過整合尖端定序和診斷技術，促進個別化治療策略的製定，從而改善患者護理。 NeoGenomics Laboratories Inc.是一家總部位於美國的免疫基因組學檢測服務公司。

免疫基因組學市場還包括提供免疫譜分析、生物資訊分析、生物標記發現和免疫療法支持等服務的營業單位所獲得的收入。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。免疫基因組學市場還包括定序試劑套件、試劑、微陣列和生物資訊學工具的銷售。該市場的價值是“出廠價”，即產品製造商或創建者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創建者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球免疫基因體學：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球免疫基因組學市場：成長率分析
  • 全球免疫基因體學市場表現：規模與成長，2019-2024年
  • 全球免疫基因組學市場預測：規模與成長，2024-2029年，2034年預測
  • 全球免疫基因體學：潛在市場規模 (TAM)

第6章 市場細分

  • 全球免疫基因組學市場（按產品類型分類）：實際數據和預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 裝置
  • 消耗品
  • 軟體
  • 服務
  • 全球免疫基因體學市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 次世代定序儀
  • 微陣列
  • 聚合酵素鏈鎖反應
  • 其他技術
  • 全球免疫基因體學市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 腫瘤學
  • 感染疾病
  • 自體免疫疾病
  • 移植
  • 其他用途
  • 全球免疫基因組學市場：依最終用戶分類，實際數據和預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 醫院和診所
  • 研究所
  • 製藥和生物技術公司
  • 其他最終用戶
  • 全球免疫基因體學市場：依儀器、類型、表現和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 序列器
  • 微陣列掃描儀
  • 流式細胞儀
  • 全球免疫基因體學市場：按耗材、類型、實際值和預測值分類的細分市場，2019-2024年、2024-2029年預測值、2034年預測值
  • 試劑
  • 套件
  • 檢測組
  • 全球免疫基因體學市場：依軟體、類型、實際值及預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 數據分析軟體
  • 生物資訊學工具
  • 視覺化平台
  • 全球免疫基因體學市場：按服務、類型、表現和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 定序服務
  • 基因組分析
  • 生物資訊支持

第7章 區域和國家分析

  • 全球免疫基因體學市場：區域表現及預測，2019-2024年、2024-2029年預測、2034年預測
  • 全球免疫基因體學市場：國家、市場表現及預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 免疫基因體學市場：競爭格局
  • 免疫基因組學市場：公司概況
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • CareDx Inc.
  • Oxford Nanopore Technologies plc
  • Genewiz LLC
  • Adaptive Biotechnologies Corporation
  • GenomOncology LLC
  • Personalis Inc.
  • Variantyx Inc.
  • CD Genomics Inc.
  • Sengenics Corporation
  • GeneCentric Therapeutics Inc.
  • Immunogenomics Inc.
  • ImmuQuad Biotechnologies Inc.
  • Neomics Pharmaceuticals LLC
  • Yemaachi Biotech Ltd.
  • BioAnalytica Biotechnology Systems Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年免疫基因體學市場：提供新機會的國家
  • 2029年免疫基因體學市場：新興細分市場機會
  • 2029年免疫基因體學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38553

Immunogenomics is a branch of genomics that examines how an individual's genetic makeup influences the immune system's function. It focuses on identifying genetic variations that impact immune responses, susceptibility to infections and autoimmune diseases, and the effectiveness of immunotherapies and vaccines.

The primary product types of immunogenomics include instruments, consumables, software, and services. Instruments are laboratory devices used to analyze genetic material and study the immune system, including sequencers, microarray scanners, and cell sorters. Technologies employed include next-generation sequencing, microarray, polymerase chain reaction, and others. Applications span oncology, infectious diseases, autoimmune disorders, transplantation, and more, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The immunogenomics market research report is one of a series of new reports from The Business Research Company that provides immunogenomics market statistics, including immunogenomics industry global market size, regional shares, competitors with an immunogenomics market share, detailed immunogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the immunogenomics industry. This immunogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunogenomics market size has grown rapidly in recent years. It will grow from $5.24 billion in 2024 to $6.09 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be linked to rising prevalence of autoimmune diseases, increasing demand for personalized medicine, greater awareness of immunogenomic testing, government funding for healthcare research, and expansion of the biotechnology and pharmaceutical sectors.

The immunogenomics market size is expected to see rapid growth in the next few years. It will grow to $11.00 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be linked to wider adoption of immunogenomic-based therapies, expansion of precision medicine initiatives, increased investment in research and development, growth of healthcare infrastructure, and rising demand for diagnostic solutions. Key trends during the forecast period include advancements in sequencing and genotyping technologies, innovations in immunogenomic assays, progress in bioinformatics and data analysis, development of targeted therapies, and integration of artificial intelligence in immunogenomics.

The rising prevalence of infectious diseases is expected to drive the growth of the immunogenomics market in the near future. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that can spread directly or indirectly from one person to another. The increasing frequency of these diseases is largely attributed to greater global travel, which facilitates the rapid transmission of pathogens across borders. Immunogenomics aids in managing infectious diseases by providing a precise analysis of host immune responses and genetic susceptibility. This approach reduces the trial-and-error nature of treatments by identifying patient-specific immune factors, which helps improve diagnostics, vaccine development, and personalized therapeutic strategies. For example, in February 2024, the UK Health Security Agency reported a 10.7% increase in tuberculosis cases in England, with 4,850 cases in 2023 compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is fueling the growth of the immunogenomics market.

Leading companies in the immunogenomics market are focusing on developing advanced technologies, such as single-cell transcriptome solutions, to provide high-resolution analysis of immune cell diversity and enhance the understanding of complex immune responses. Single-cell transcriptome solutions analyze the complete set of RNA transcripts in individual cells, offering insights into gene expression patterns and cellular heterogeneity within complex tissues. For example, in October 2022, Pacific Biosciences of California Inc. partnered with the Broad Institute of MIT and Harvard, along with 10x Genomics Inc., to launch a Multiplexed Arrays Sequencing (MAS-Seq) kit. This high-throughput, cost-effective sequencing solution enables the full-length analysis of single-cell RNA transcripts, uncovering novel RNA isoforms and mutations with exceptional accuracy. The technology increases sequencing throughput by 16 times by concatenating cDNA molecules and integrates seamlessly with 10x Genomics' single-cell technology and PacBio sequencers. This solution allows researchers to explore cellular heterogeneity at the isoform level, advancing disease research and biomarker discovery.

In January 2025, Adaptive Biotechnologies Corp., a US-based biotechnology firm, partnered with NeoGenomics Laboratories Inc. to enhance advanced immunogenomic testing services. This collaboration aims to expand access to personalized minimal residual disease (MRD) monitoring for blood cancer patients, facilitating tailored treatment strategies and improving patient care through the integration of cutting-edge sequencing and diagnostic technologies. NeoGenomics Laboratories Inc. is a US-based company that specializes in immunogenomics testing services.

Major players in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., and BioAnalytica Biotechnology Systems Inc.

North America was the largest region in the immunogenomics market in 2024. The regions covered in immunogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunogenomics market also consists of revenues earned by entities by providing services such as immune profiling, bioinformatics analysis, biomarker discovery, and immunotherapy support. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunogenomics market also includes sales of sequencing kits, reagents, microarrays, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunogenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunogenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunogenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunogenomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Consumables; Software; Services
  • 2) By Technology: Next-Generation Sequencing; Microarray; Polymerase Chain Reaction; Other Technologies
  • 3) By Application: Oncology; Infectious Diseases; Autoimmune Disorders; Transplantation; Other Applications
  • 4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Instruments: Sequencers; Microarray scanners; Flow cytometers
  • 2) By Consumables: Reagents; Kits; Assay panels
  • 3) By Software: Data analysis software; Bioinformatics tools; Visualization platforms
  • 4) By Services: Sequencing services; Genomic profiling; Bioinformatics support
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Illumina Inc.; BGI Group; GenScript Biotech Corporation; CareDx Inc.; Oxford Nanopore Technologies plc; Genewiz LLC; Adaptive Biotechnologies Corporation; GenomOncology LLC; Personalis Inc.; Variantyx Inc.; CD Genomics Inc.; Sengenics Corporation; GeneCentric Therapeutics Inc.; Immunogenomics Inc.; ImmuQuad Biotechnologies Inc.; Neomics Pharmaceuticals LLC; Yemaachi Biotech Ltd.; BioAnalytica Biotechnology Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunogenomics Market Characteristics

3. Immunogenomics Market Trends And Strategies

4. Immunogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunogenomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunogenomics Market Growth Rate Analysis
  • 5.4. Global Immunogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunogenomics Total Addressable Market (TAM)

6. Immunogenomics Market Segmentation

  • 6.1. Global Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Software
  • Services
  • 6.2. Global Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Other Technologies
  • 6.3. Global Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Infectious Diseases
  • Autoimmune Disorders
  • Transplantation
  • Other Applications
  • 6.4. Global Immunogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.5. Global Immunogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • Microarray scanners
  • Flow cytometers
  • 6.6. Global Immunogenomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Kits
  • Assay panels
  • 6.7. Global Immunogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data analysis software
  • Bioinformatics tools
  • Visualization platforms
  • 6.8. Global Immunogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing services
  • Genomic profiling
  • Bioinformatics support

7. Immunogenomics Market Regional And Country Analysis

  • 7.1. Global Immunogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunogenomics Market

  • 8.1. Asia-Pacific Immunogenomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunogenomics Market

  • 9.1. China Immunogenomics Market Overview
  • 9.2. China Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunogenomics Market

  • 10.1. India Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunogenomics Market

  • 11.1. Japan Immunogenomics Market Overview
  • 11.2. Japan Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunogenomics Market

  • 12.1. Australia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunogenomics Market

  • 13.1. Indonesia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunogenomics Market

  • 14.1. South Korea Immunogenomics Market Overview
  • 14.2. South Korea Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunogenomics Market

  • 15.1. Western Europe Immunogenomics Market Overview
  • 15.2. Western Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunogenomics Market

  • 16.1. UK Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunogenomics Market

  • 17.1. Germany Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunogenomics Market

  • 18.1. France Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunogenomics Market

  • 19.1. Italy Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunogenomics Market

  • 20.1. Spain Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunogenomics Market

  • 21.1. Eastern Europe Immunogenomics Market Overview
  • 21.2. Eastern Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunogenomics Market

  • 22.1. Russia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunogenomics Market

  • 23.1. North America Immunogenomics Market Overview
  • 23.2. North America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunogenomics Market

  • 24.1. USA Immunogenomics Market Overview
  • 24.2. USA Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunogenomics Market

  • 25.1. Canada Immunogenomics Market Overview
  • 25.2. Canada Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunogenomics Market

  • 26.1. South America Immunogenomics Market Overview
  • 26.2. South America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunogenomics Market

  • 27.1. Brazil Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunogenomics Market

  • 28.1. Middle East Immunogenomics Market Overview
  • 28.2. Middle East Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunogenomics Market

  • 29.1. Africa Immunogenomics Market Overview
  • 29.2. Africa Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunogenomics Market Competitive Landscape And Company Profiles

  • 30.1. Immunogenomics Market Competitive Landscape
  • 30.2. Immunogenomics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Immunogenomics Market Other Major And Innovative Companies

  • 31.1. CareDx Inc.
  • 31.2. Oxford Nanopore Technologies plc
  • 31.3. Genewiz LLC
  • 31.4. Adaptive Biotechnologies Corporation
  • 31.5. GenomOncology LLC
  • 31.6. Personalis Inc.
  • 31.7. Variantyx Inc.
  • 31.8. CD Genomics Inc.
  • 31.9. Sengenics Corporation
  • 31.10. GeneCentric Therapeutics Inc.
  • 31.11. Immunogenomics Inc.
  • 31.12. ImmuQuad Biotechnologies Inc.
  • 31.13. Neomics Pharmaceuticals LLC
  • 31.14. Yemaachi Biotech Ltd.
  • 31.15. BioAnalytica Biotechnology Systems Inc.

32. Global Immunogenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunogenomics Market

34. Recent Developments In The Immunogenomics Market

35. Immunogenomics Market High Potential Countries, Segments and Strategies

  • 35.1 Immunogenomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunogenomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunogenomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer